DE2506099C2 - Sulfonamid und Trimethoprim enthaltende Tablette - Google Patents

Sulfonamid und Trimethoprim enthaltende Tablette

Info

Publication number
DE2506099C2
DE2506099C2 DE2506099A DE2506099A DE2506099C2 DE 2506099 C2 DE2506099 C2 DE 2506099C2 DE 2506099 A DE2506099 A DE 2506099A DE 2506099 A DE2506099 A DE 2506099A DE 2506099 C2 DE2506099 C2 DE 2506099C2
Authority
DE
Germany
Prior art keywords
tablet
trimethoprim
weight
tablets
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2506099A
Other languages
German (de)
English (en)
Other versions
DE2506099A1 (de
Inventor
David Sidcup Kent Harden
John Bickley Kent Spence
Allan John Basildon Essex Torode
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE2506099(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2506099A1 publication Critical patent/DE2506099A1/de
Application granted granted Critical
Publication of DE2506099C2 publication Critical patent/DE2506099C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE2506099A 1974-02-14 1975-02-13 Sulfonamid und Trimethoprim enthaltende Tablette Expired DE2506099C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (2)

Publication Number Publication Date
DE2506099A1 DE2506099A1 (de) 1975-08-21
DE2506099C2 true DE2506099C2 (de) 1983-11-03

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2506099A Expired DE2506099C2 (de) 1974-02-14 1975-02-13 Sulfonamid und Trimethoprim enthaltende Tablette

Country Status (32)

Country Link
JP (1) JPS5545043B2 (es)
AT (1) AT344915B (es)
AU (1) AU468465B2 (es)
BE (1) BE825496A (es)
CA (1) CA980688A (es)
CH (1) CH618432A5 (es)
CS (1) CS220306B2 (es)
CY (1) CY1052A (es)
DD (1) DD118228A5 (es)
DE (1) DE2506099C2 (es)
DK (1) DK143247C (es)
DO (1) DOP1979002763A (es)
ES (1) ES434688A1 (es)
FI (1) FI62219C (es)
FR (1) FR2260993B1 (es)
GB (1) GB1499672A (es)
GT (1) GT197960431A (es)
HK (1) HK23980A (es)
HU (1) HU171536B (es)
IE (1) IE40599B1 (es)
IL (1) IL46629A (es)
IN (1) IN141019B (es)
KE (1) KE3038A (es)
LU (1) LU71835A1 (es)
MC (1) MC1053A1 (es)
MY (1) MY8100054A (es)
NL (1) NL157501C (es)
NO (1) NO146043C (es)
PH (1) PH14575A (es)
SE (1) SE427898B (es)
ZA (1) ZA75930B (es)
ZM (1) ZM1875A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
NO146043B (no) 1982-04-13
JPS5545043B2 (es) 1980-11-15
CS220306B2 (en) 1983-03-25
FR2260993A1 (es) 1975-09-12
GB1499672A (en) 1978-02-01
GT197960431A (es) 1981-05-05
HK23980A (en) 1980-05-09
ES434688A1 (es) 1977-04-01
HU171536B (hu) 1978-01-28
DK143247B (da) 1981-08-03
NL7501680A (nl) 1975-08-18
PH14575A (en) 1981-09-24
CY1052A (en) 1980-08-01
IL46629A0 (en) 1975-05-22
DK52875A (es) 1975-10-06
CA980688A (en) 1975-12-30
IE40599B1 (en) 1979-07-04
JPS50116627A (es) 1975-09-12
DOP1979002763A (es) 1987-06-18
KE3038A (en) 1980-04-25
DE2506099A1 (de) 1975-08-21
IN141019B (es) 1977-01-08
AU7817075A (en) 1976-01-15
ZA75930B (en) 1976-01-28
MY8100054A (en) 1981-12-31
FI62219C (fi) 1982-12-10
DD118228A5 (es) 1976-02-20
IE40599L (en) 1975-08-14
AU468465B2 (en) 1976-01-15
CH618432A5 (en) 1980-07-31
ATA108475A (de) 1977-12-15
ZM1875A1 (en) 1975-12-22
BE825496A (fr) 1975-05-29
DK143247C (da) 1981-11-30
NL157501C (nl) 1981-07-16
NO146043C (no) 1982-08-04
MC1053A1 (fr) 1976-02-20
SE427898B (sv) 1983-05-24
FR2260993B1 (es) 1978-06-30
LU71835A1 (es) 1975-06-24
IL46629A (en) 1977-07-31
FI62219B (fi) 1982-08-31
SE7501595L (es) 1975-08-15
NO750467L (es) 1975-08-15
FI750398A (es) 1975-08-15
AT344915B (de) 1978-08-25
NL157501B (nl) 1978-08-15

Similar Documents

Publication Publication Date Title
DE3688674T2 (de) Hydroxypropylcelluloseether enthaltende Mittel mit verzögerter Wirkstoffabgabe.
DE3880762T2 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
DE68916983T2 (de) Verfahren zur Herstellung eines pharmazeutischen Granulats.
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
DE60316552T2 (de) Tablette mit hohem wirkstoffgehalt
DE69400356T2 (de) Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten
DE2553239A1 (de) Verfahren zur herstellung von niedrig substituierten zelluloseaethern
DE60224056T2 (de) Antazide und laxative magnesiumoxid-tablette
US4209513A (en) Tablet formulation
DE3650716T2 (de) Trimethoprim und ein Sulfonamid enthaltende Tabletten
AT397345B (de) Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen
DE60103247T2 (de) Verfahren zur Herstellung von Formulierungen zur Direkttablettierung
DE2506099C2 (de) Sulfonamid und Trimethoprim enthaltende Tablette
DE2200778B2 (de) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
DE60129515T2 (de) Basismaterial zur trockenen Direkttablettierung enthaltend niedrig substituierte Hydroxypropylcellulose
EP0146863A2 (de) Orale retardierte Acetylsalicylsäureformulierungen
DE1492253A1 (de) Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung
DE3150557C2 (es)
EP0414115A1 (de) Hilfsmittelfreie Riboflavingranulate
DE60005469T2 (de) Arzneizusammensetzung enthaltend Ascorbinsäure und Pektin
EP0537139B1 (de) Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit
DE2050701C3 (de) Verwendung eines pulverförmigen Celluloseäthers als Hilfsstoff zur Herstellung von leicht zerfallbaren festen Arzneiformen
DE60206940T2 (de) Pektin und ascorbinsäure enthaltende zusammensetzungen
Bahadur et al. Formulation and evaluation of glipizide tablets utilizing Hibiscus rosasinensis leaves mucilage
DE69330392T2 (de) Cytarabine Ocfosfate enthaltende harte Kapsel

Legal Events

Date Code Title Description
8181 Inventor (new situation)

Free format text: TORODE, ALLAN JOHN, BASILDON, ESSEX, GB HARDEN, DAVID, SIDCUP, KENT, GB SPENCE, JOHN, BICKLEY, KENT, GB

D2 Grant after examination
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Free format text: BERG, W., DIPL.-CHEM. DR.RER.NAT. SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM. DR.JUR. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN

8365 Fully valid after opposition proceedings
8328 Change in the person/name/address of the agent

Free format text: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM. DR.JUR. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8310 Action for declaration of annulment
8311 Complete invalidation